Diagnostic accuracy of the triage D-dimer test for exclusion of venous thromboembolism in outpatients

Timothy Ghys, Wim Achtergael, Inge Verschraegen, Barbara Leus, Kristin Jochmans

    Research output: Contribution to journalArticlepeer-review

    18 Citations (Scopus)

    Abstract

    BACKGROUND: We evaluated the diagnostic performance of the Triage D-dimer test, a new fast quantitative point-of-care whole blood D-dimer assay and compared it with the Vidas D-dimer assay.

    MATERIALS AND METHODS: The study population comprised 319 outpatients for whom D-dimer testing was requested in order to rule out venous thromboembolism (VTE). Routine testing consisted of a plasma ELISA D-dimer analysis (Vidas). For all included patients, an additional EDTA whole blood D-dimer test (Triage) was performed. Patients were classified by reference imaging or by follow-up of the medical record. Accuracy indices, receiver operating characteristics and the kappa coefficient for agreement were calculated using the cutoff values recommended by the manufacturer.

    RESULTS: Prevalence of VTE was 14%. Sensitivity and specificity for VTE were 98% (95%CI: 88-100) and 34% (95%CI: 28-40) for Vidas and 91% (95%CI: 78-97) and 42% (95%CI: 36-48) for Triage, respectively. The differences in sensitivity and specificity between both D-dimer assays were statistically significant (McNemar, p
    CONCLUSIONS: The Triage and Vidas D-dimer tests show comparable diagnostic accuracy. Vidas showed a significant higher sensitivity. Our findings strongly suggest lowering the cutoff for the Triage D-dimer test from 400 to 350 ng/mL. In this way specificity lowers from 42 to 38%, but, more importantly, sensitivity increases from 91 to 95%.
    Original languageEnglish
    Pages (from-to)735-741
    Number of pages7
    JournalThrombosis Research
    Volume121
    Publication statusPublished - 2008

    Keywords

    • venous thromboembolism

    Fingerprint

    Dive into the research topics of 'Diagnostic accuracy of the triage D-dimer test for exclusion of venous thromboembolism in outpatients'. Together they form a unique fingerprint.

    Cite this